EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

SGO1 and SGO2 are Associated With Disease Progression and an Immunosuppressive Microenvironment in Papillary Renal Cell Carcinoma

Han Fu, Alisherjon Ibrohimov, Hao Zheng, Yue Pan, Jieyu Hu, Banzhan Ruan, Hang Huang, Shi Li iD

Cancer Medicine · 2026-06 · 15 (6)

DOI: 10.1002/cam4.72034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 12.06.2026. Verfasst von Han Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Tumor Microenvironment, Kidney Neoplasms. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Zhejiang Province Medical and Health Science and Technology Plan Project, the Hainan Provincial Association for Science and Technology Young Talent Innovation Program, the Hainan Provincial Natural Science Foundation High-level Talent Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Shugoshin proteins SGO1 and SGO2 regulate chromosome cohesion and segregation during mitosis and meiosis, and their aberrant expression is implicated in several cancers. However, the mechanistic involvement of these two proteins in papillary renal cell carcinoma (KIRP) and their contribution to immune evasion remains unclear. Therefore, in the present study, we aimed to determine SGO1 and SGO2 expression patterns and prognostic significance, clarify their functional involvement in driving tumor progression, and evaluate their impact on the tumor immune microenvironment.

Methods

We performed an integrative analysis using multi‐omics datasets retrieved from TCGA, GTEx, and GEO, complemented by single‐cell transcriptomics, immunohistochemistry of patient samples, and functional assays in renal cancer cell lines. We also investigated the expression, clinical relevance, and mechanistic roles of SGO1 and SGO2 in KIRP progression and tumor immune regulation.

Results

SGO1 and SGO2 were significantly upregulated in KIRP, correlating with advanced tumor stage and poor overall survival. Receiver operating characteristic analyses demonstrated strong diagnostic performance, particularly when SGO1 and SGO2 were evaluated jointly. Functional knockdown experiments revealed that both SGO1 and SGO2 promote the proliferation, migration, and invasion of renal cancer cells. Gene enrichment analyses further linked these proteins to E2F signaling, genomic stability, and immune‐related pathways. Importantly, high SGO1 and SGO2 expression was strongly associated with increased infiltration of immunosuppressive cells, including regulatory T cells, M2 macrophages, cancer‐associated fibroblasts, and myeloid‐derived suppressor cells, suggesting their potential contribution to an immune‐evasive tumor microenvironment.

Conclusions

SGO1 and SGO2 are associated with aggressive tumor biology in papillary renal cell carcinoma and correlate with remodeling of the tumor immune microenvironment toward an immunosuppressive state. Importantly, while these findings highlight a strong association with the tumor immune microenvironment, they remain correlative, and further mechanistic studies are warranted to establish a direct causal relationship. Nevertheless, their associations with both tumor progression and immunosuppressive features suggest potential as prognostic biomarkers and targets for future mechanistic studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellTumor MicroenvironmentKidney NeoplasmsHumansDisease ProgressionPrognosisCell Line, TumorGene Expression Regulation, NeoplasticFemaleBiomarkers, TumorCell ProliferationMale

Stichwörter der Autor:innen

SGO1SGO2immune microenvironmentpapillary renal cell carcinomaprognosis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University, Wenzhou, China.
  • Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University, Wenzhou, China.
  • Department of Oncology of the First Affiliated Hospital and Tumor Institute, Hainan Medical University, Haikou, China.

ORCID-Profile: Shi Li

Förderung

  • Zhejiang Province Medical and Health Science and Technology Plan Project
  • the Hainan Provincial Association for Science and Technology Young Talent Innovation Program
  • the Hainan Provincial Natural Science Foundation High-level Talent Project
  • the Beijing Xisike Clinical Oncology Research Foundation

Zitieren

APA

Fu, H., Ibrohimov, A., Zheng, H., Pan, Y., Hu, J., Ruan, B., Huang, H., & Li, S. (2026). SGO1 and SGO2 are Associated With Disease Progression and an Immunosuppressive Microenvironment in Papillary Renal Cell Carcinoma. Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.72034

Vancouver

Fu H, Ibrohimov A, Zheng H, Pan Y, Hu J, Ruan B, et al. SGO1 and SGO2 are Associated With Disease Progression and an Immunosuppressive Microenvironment in Papillary Renal Cell Carcinoma. Cancer Medicine. 2026;15(6). doi:10.1002/cam4.72034

BibTeX
@article{Fu2026,
  author = {Fu, Han and Ibrohimov, Alisherjon and Zheng, Hao and Pan, Yue and Hu, Jieyu and Ruan, Banzhan and Huang, Hang and Li, Shi},
  title = {SGO1 and SGO2 are Associated With Disease Progression and an Immunosuppressive Microenvironment in Papillary Renal Cell Carcinoma},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {6},
  doi = {10.1002/cam4.72034}
}
Kostenlos starten →